glp 1 and dpp 4 inhibitors DPP4 Inhibitor Mechanism of Action – My Endo Consult DPP4 Inhibitors vs GLP-1 Agonists

Altimmune just made a big move in the world of GLP-1 research, but this time, its not about obesity.The company announced yesterday that it has officially begun enrolling participants in a Phase 2 trial of pemvidutide, its GLP-1 and glucagon dual receptor agonist, to evaluate the drug in people with Alcohol Use Disorder, or AUD

Evaluating what the research shows about GLP-1 medications and depression and suicidal ideation.

A four-minute drive north of the Illinois-Wisconsin border in 'America's Dairyland,' Eli Lilly is staking one of its largest-ever manufacturing bets to continue its dominance in obesity drugs and support a deep pipeline of next-generation medicines for the most lucrative pharmaceutical market.

GLP-1 2.0: where will the next wave of value come from

Feel more like yourself again

Were now seeing a real shift: from weekly injections to once-daily pills Two oral GLP-1 options are now leading this transition: #Wegovy pill (oral semaglutide) first to market #Foundayo (orforglipron) newest entrant But heres what you must know